A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Eli M. Wallace.

Business address: C/O Bridgebio Oncology Therapeutics, Inc, 256 E. Grand Avenue, Suite 104, South San Francisco, CA, 94080

Get insider transactions for this reporting owner

Eli M. Wallace has filed 5 SEC EDGAR filings since 18 Aug 2025

Recent SEC filings for Eli M. Wallace including 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	4	05 Jan 2026	01 Jan 2026	001-41955
4	Open 4 document	View SEC filing for 4	4	12 Dec 2025	10 Dec 2025	001-41955
4	Open 4 document	View SEC filing for 4	4	06 Oct 2025	02 Oct 2025	001-41955
4	Open 4 document	View SEC filing for 4	4	28 Aug 2025	26 Aug 2025	001-41955
3	Open 3 document	View SEC filing for 3	3	18 Aug 2025	11 Aug 2025	001-41955

Eli M. Wallace files with the SEC under CIK 0001776352. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.